Evolution of siglec-11 and siglec-16 genes in hominins

Molecular Biology and Evolution

Volumn 29, Issue 8, 2012, Pages 2073-2086

  Wang, Xiaoxia ^a,b,c   Mitra, Nivedita ^a,b,c   Cruz, Pedro ^d   Deng, Liwen ^d,e   Varki, Nissi ^e   Angata, Takashi ^f   Green, Eric D ^d   Mullikin, Jim ^d   Hayakawa, Toshiyuki ^g   Varki, Ajit ^a,b,c  

^a University of California San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f RIKEN   (Japan)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

gene conversion; human brain; human evolution; microglia; pseudogene

Indexed keywords

PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 1; SIGLEC 11 PROTEIN; SIGLEC 16 PROTEIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ALLELE; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL SURVIVAL; CHIMPANZEE; CONTROLLED STUDY; DENISOVAN; EVOLUTION; GENE CONVERSION; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; HAPLOTYPE; HAPLOTYPE MAP; HETEROZYGOTE; HOMINID; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; MICROGLIA; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ORANG UTAN; PHYLOGENETIC TREE; PROTEIN BINDING; PROTEIN EXPRESSION; PSEUDOGENE;

5' UNTRANSLATED REGIONS; ADULT; ALLELES; ANIMALS; BASE SEQUENCE; BINDING SITES; BRAIN; CELL LINE; EVOLUTION, MOLECULAR; GENE CONVERSION; GENE FREQUENCY; GENETIC LOCI; GENETICS, POPULATION; HOMINIDAE; HUMANS; LIGANDS; MICE; MICROGLIA; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOGENES; SEQUENCE ALIGNMENT; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS; TRANSCRIPTION FACTORS;

EID: 84862561617     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/mss077     Document Type: Article

References (58)

1. Angata T, Hayakawa T, Yamanaka M, Varki A, Nakamura M. 2006. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J. 20: 1964-1973
2. Angata T, Kerr SC, Greaves DR, Varki NM, Crocker PR, Varki A. 2002. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J Biol Chem. 277:24466-24474.
3. Angata T, Varki A. 2002. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev. 102:439-469.
4. Benatar T, Ratcliffe MJ. 1993. Polymorphism of the functional immunoglobulin variable region genes in the chicken by exchange of sequence with donor pseudogenes. Eur J Immunol. 23:2448-2453.
5. Boocock GR, Morrison JA, Popovic M, Richards N, Ellis L, Durie PR, Rommens JM. 2003. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 33:97-101.
6. Cao H, Crocker PR. 2011. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology 132:18-26.
7. Cao H, Lakner U, de Bono B, Traherne JA, Trowsdale J, Barrow AD. 2008. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur J Immunol. 38:2303-2315.
8. Carlin AF, Chang YC, Areschoug T, Lindahl G, Hurtado-Ziola N, King CC, Varki A, Nizet V. 2009. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J Exp Med. 206:1691-1699.
9. Chen JM, Cooper DN, Chuzhanova N, Ferec C, Patrinos GP. 2007. Gene conversion: mechanisms, evolution and human disease. Nat Rev Genet. 8:762-775.
10. Chen X, Varki A. 2010. Advances in the biology and chemistry of sialic acids. ACS Chem Biol. 5:163-176.
11. Chuzhanova N, Chen JM, Bacolla A, Patrinos GP, Ferec C, Wells RD, Cooper DN. 2009. Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair. Hum Mutat. 30:1189-1198.
12. Cormand B, Diaz A, Grinberg D, Chabas A, Vilageliu L. 2000. A new gene-pseudogene fusion allele due to a recombination in intron 2 of the glucocerebrosidase gene causes Gaucher disease. Blood Cells Mol Dis. 26:409-416.
13. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol. 7:255-266.
14. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD. 2007. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med. 13:432-438.
15. Flajnik MF. 2002. Comparative analyses of immunoglobulin genes: surprises and portents. Nat Rev Immunol. 2:688-698.
16. Forest MG. 2004. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update. 10:469-485.
17. Fuhrmann M, Bittner T, Jung CK, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, Herms J. 2010. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci. 13:411-413.
18. Ginhoux F, Greter M, Leboeuf M, et al. (12 co-authors). 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841-845.
19. Green RE, Krause J, Briggs AW, et al. (56 co-authors). 2010. A draft sequence of the Neandertal genome. Science 328:710-722.
20. Griffiths RC. 2002. Ancestral inference from gene trees. In: Slatkin M, Venuille M, editors. Modern developments in theoretical population genetics. New York: Oxford University Press. p. 94-117.
21. Griffiths RC, Tavare S. 1994. Simulating probability distribution in the coalescent. Theor Popul Biol. 46:131-159.
22. Guillemin GJ, Brew BJ. 2004. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol. 75:388-397.
23. Hanisch UK, Kettenmann H. 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 10:1387-1394.
24. Hayakawa T, Angata T, Lewis AL, Mikkelsen TS, Varki NM, Varki A. 2005. A human-specific gene in microglia. Science 309:1693.
25. Inoko E, Nishiura Y, Tanaka H, Takahashi T, Furukawa K, Kitajima K, Sato C. 2010. Developmental stage-dependent expression of an alpha2,8-trisialic acid unit on glycoproteins in mouse brain. Glycobiology 20:916-928.
26. Jukes TH, Cantor CR. 1969. Evolution of protein molecules. In: Munro HN, editor. Mammalian protein metabolism III. New York: Academic Press. p. 21-132.
27. Lange-Dohna C, Zeitschel U, Gaunitz F, Perez-Polo JR, Bigl V, Rossner S. 2003. Cloning and expression of the rat BACE1 promoter. J Neurosci Res. 73:73-80.
28. Lu YZ, Lin CH, Cheng FC, Hsueh CM. 2005. Molecular mechanisms responsible for microglia-derived protection of Sprague-Dawley rat brain cells during in vitro ischemia. Neurosci Lett. 373:159-164.
29. Matys V, Kel-Margoulis OV, Fricke E, et al. (16 co-authors). 2006. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 34:D108-D110.
30. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. 2002. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: hIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci. 202:13-23.
31. Monsonego A, Weiner HL. 2003. Immunotherapeutic approaches to Alzheimer's disease. Science 302:834-838.
32. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 308:1314-1318.
33. Patel N, Brinkman-Van der Linden ECM, Altmann SW, et al. (11 co-authors). 1999. OB-BP1/Siglec-6-A leptin-and sialic acidbinding protein of the immunoglobulin superfamily. J Biol Chem. 274:22729-22738.
34. Perlmutter LS, Scott SA, Barron E, Chui HC. 1992. MHC class IIpositive microglia in human brain: association with Alzheimer lesions. J Neurosci Res. 33:549-558.
35. Ransohoff RM, Perry VH. 2009. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol. 27:119-145.
36. Reich D, Green RE, Kircher M, et al. (28 co-authors). 2010. Genetic history of an archaic hominin group from Denisova Cave in Siberia. Nature 468:1053-1060.
37. Rozas J, Rozas R. 1999. DnaSP version 3: an integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics 15:174-175.
38. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 4:406-425.
39. Salminen A, Kaarniranta K. 2009. Siglec receptors and hiding plaques in Alzheimer's disease. J Mol Med. 87:697-701.
40. Sato C, Fukuoka H, Ohta K, Matsuda T, Koshino R, Kobayashi K, Troy FAII, Kitajima K. 2000. Frequent occurrence of pre-existing alpha2->8-linked disialic and oligosialic acids with chain lengths up to 7 Sia residues in mammalian brain glycoproteins-prevalence revealed by highly sensitive chemical methods and anti-di-, oligo-, and poly-Sia antibodies specific for defined chain lengths. J Biol Chem. 275:15422-15431.
41. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell proteintyrosine phosphatase (Hcph) gene. Cell 73:1445-1454.
42. Stephens M, Scheet P. 2005. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 76:449-462.
43. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 68:978-989.
44. Streit WJ. 2004. Microglia and Alzheimer's disease pathogenesis. J Neurosci Res. 77:1-8.
45. Takezaki N, Rzhetsky A, Nei M. 1995. Phylogenetic test of the molecular clock and linearized trees. Mol Biol Evol. 12:823-833.
46. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol. 24:1596-1599.
47. Tusie-Luna MT, White PC. 1995. Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci U S A. 92:10796-10800.
48. Varki A. 2011. Since there are PAMPs and DAMPs, there must be SAMPs? Glycan ''self-associated molecular patterns'' dampen innate immunity, but pathogens can mimic them. Glycobiology 21:1121-1124.
49. Varki A, Angata T. 2006. Siglecs-the major subfamily of I-type lectins. Glycobiology 16:1R-27R.
50. Varki A, Schauer R. 2009. Sialic acids. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of glycobiology, 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press. p. 199-218.
51. Varki NM, Strobert E, Dick EJ, Benirschke K, Varki A. 2011. Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology. Annu Rev Pathol. 6:365-393.
52. von Gunten S, Bochner BS. 2008. Basic and clinical immunology of Siglecs. Ann N Y Acad Sci. 1143:61-82.
53. Wang X, Chow R, Deng L, et al. (11 co-authors). 2011. Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology. Glycobiology 21:1038-1048.
54. Wang Y, Neumann H. 2010. Alleviation of neurotoxicity by microglial human Siglec-11. J Neurosci. 30:3482-3488.
55. Whitney G, Wang S, Chang H, Cheng KY, Lu P, Zhou XD, Yang WP, McKinnon M, Longphre M. 2001. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur J Biochem. 268:6083-6096.
56. Wishcamper CA, Coffin JD, Lurie DI. 2001. Lack of the protein tyrosine phosphatase SHP-1 results in decreased numbers of glia within the motheaten (me/me) mouse brain. J Comp Neurol. 441:118-133.
57. Zhang M, Angata T, Cho JY, Miller M, Broide DH, Varki A. 2007. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood 109: 4280-4287.
58. Zhao J, Brooks DM, Lurie DI. 2006. Lipopolysaccharide-activated SHP-1-deficient motheaten microglia release increased nitric oxide, TNF-alpha, and IL-1beta. Glia 53:304-312.